Seed VC · USA

ARCH Venture Partners

Check size: $50K to $150K

Active

What they invest in

ARCH builds disruptive companies by bringing together scientific founders, groundbreaking science and technology, and substantial capital to pursue big missions with long-term commitment rather than quick returns.

Who they back

DeepTechHealthtechBiotechHealth & BiotechPre-seedSeedSeries ASeries B+

Business models

biotech_therapeutics, deeptech_ip

Customer segments

Researchers, Patients

Geography

US

Recent investments

  • Agios Pharmaceuticals
  • Denali Therapeutics
  • Grail (Acquired)

+ 9 more deals. Score your deck to see the full investment history.

The people who write checks

12 partners on file at ARCH Venture Partners, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

ARCH Venture Partners writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks ARCH Venture Partners alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United States
Last known deal
Oct 2019
Portfolio last checked
Oct 6, 2026
Website
www.archventure.com/portfolio ↗

Other firms investing in DeepTech

See all investors

Is ARCH Venture Partners the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. ARCH Venture Partners is one of them, and we'll tell you exactly where they sit in your top 100.